New Guidelines: Medicare To Directly Negotiate Drug Prices
The Biden administration has issued new guidelines for its program that enables Medicare to directly negotiate drug prices with manufacturers. The updated guidelines provide...
Environmental Consciousness Rising In Global Healthcare
The global healthcare sector is increasingly embracing environmentally conscious practices, particularly in the pharmaceutical industry, which is prioritizing initiatives aligned with environmental, social, and...
Swiss Pharma Sector In EU Negotiations- Stakes Are Sky High
In a recent development, Switzerland may very well lose out as a manufacturing location if its differences with the European Union are not sorted...
$85bn M&A Splurge Helps In Big Pharma Dealmaking Recovery
It is well to be noted that pharma and biotech companies splurged a whopping $85 billion in the first five months of 2023, which...
Advancing RNA Therapeutics With UK Drug Delivery Centre
The Centre for Process Innovation (CPI) plans to establish a new Intracellular Drug Delivery Centre in the UK to develop innovative lipid nanoparticle (LNP)...
WHO And Korea Sign MoU For Biomanufacturing Training Hub
The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a...
Switzerland Emerges As The Headquarters For European Biotech
Analysis shows Switzerland has become the chosen headquarters for 20 per cent of European biotech companies. Out of a total of 265 companies that...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...